Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$0.42 - $1.38 $264 - $869
-630 Reduced 0.85%
73,421 $49,000
Q4 2023

Feb 13, 2024

BUY
$0.3 - $0.63 $620 - $1,302
2,068 Added 2.87%
74,051 $39,000
Q3 2023

Nov 13, 2023

BUY
$0.58 - $1.47 $1,484 - $3,763
2,560 Added 3.69%
71,983 $43,000
Q2 2023

Aug 04, 2023

BUY
$1.11 - $1.74 $5,372 - $8,421
4,840 Added 7.49%
69,423 $90,000
Q1 2023

May 12, 2023

BUY
$1.66 - $3.67 $2,133 - $4,715
1,285 Added 2.03%
64,583 $113,000
Q4 2022

Feb 10, 2023

BUY
$2.77 - $5.07 $7,229 - $13,232
2,610 Added 4.3%
63,298 $198,000
Q3 2022

Nov 14, 2022

BUY
$4.27 - $6.39 $19,757 - $29,566
4,627 Added 8.25%
60,688 $297,000
Q2 2022

Aug 12, 2022

SELL
$3.28 - $6.21 $9,482 - $17,953
-2,891 Reduced 4.9%
56,061 $232,000
Q1 2022

May 13, 2022

SELL
$5.23 - $7.82 $21,699 - $32,445
-4,149 Reduced 6.58%
58,952 $343,000
Q4 2021

Feb 11, 2022

SELL
$7.29 - $10.97 $13,763 - $20,711
-1,888 Reduced 2.91%
63,101 $473,000
Q3 2021

Nov 12, 2021

SELL
$9.01 - $12.01 $7,910 - $10,544
-878 Reduced 1.33%
64,989 $586,000
Q2 2021

Aug 13, 2021

SELL
$10.17 - $12.64 $12,661 - $15,736
-1,245 Reduced 1.86%
65,867 $788,000
Q1 2021

May 07, 2021

BUY
$10.88 - $17.05 $1,925 - $3,017
177 Added 0.26%
67,112 $841,000
Q4 2020

Feb 12, 2021

SELL
$9.23 - $18.18 $17,721 - $34,905
-1,920 Reduced 2.79%
66,935 $1.05 Million
Q3 2020

Nov 04, 2020

SELL
$9.38 - $12.48 $14,689 - $19,543
-1,566 Reduced 2.22%
68,855 $651,000
Q2 2020

Aug 12, 2020

BUY
$6.21 - $11.83 $15,009 - $28,593
2,417 Added 3.55%
70,421 $631,000
Q1 2020

May 04, 2020

SELL
$5.05 - $8.85 $19,836 - $34,762
-3,928 Reduced 5.46%
68,004 $433,000
Q4 2019

Feb 05, 2020

SELL
$8.03 - $11.7 $4,858 - $7,078
-605 Reduced 0.83%
71,932 $602,000
Q3 2019

Nov 08, 2019

SELL
$9.05 - $12.22 $4,570 - $6,171
-505 Reduced 0.69%
72,537 $656,000
Q2 2019

Aug 13, 2019

BUY
$8.75 - $13.03 $73,237 - $109,061
8,370 Added 12.94%
73,042 $787,000
Q1 2019

May 06, 2019

SELL
$7.72 - $12.81 $16,181 - $26,849
-2,096 Reduced 3.14%
64,672 $617,000
Q4 2018

Feb 13, 2019

SELL
$9.51 - $16.6 $4,888 - $8,532
-514 Reduced 0.76%
66,768 $766,000
Q3 2018

Nov 09, 2018

BUY
$13.05 - $19.05 $15,816 - $23,088
1,212 Added 1.83%
67,282 $1.14 Million
Q2 2018

Aug 08, 2018

BUY
$13.9 - $19.8 $173,374 - $246,965
12,473 Added 23.27%
66,070 $938,000
Q1 2018

May 07, 2018

SELL
$16.7 - $26.35 $48,162 - $75,993
-2,884 Reduced 5.11%
53,597 $1.02 Million
Q4 2017

Feb 09, 2018

BUY
$11.6 - $17.35 $16,704 - $24,984
1,440 Added 2.62%
56,481 $926,000
Q3 2017

Nov 09, 2017

BUY
$8.4 - $15.0 $462,344 - $825,615
55,041
55,041 $826,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $180M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.